Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Quantitative gene-level inference of tumor transcription from plasma epigenomes

Across 559 plasma samples spanning 24 cancer types and clinically relevant tumor fractions, APEX outperforms existing approaches for individual-gene inference, resolves pancreatic cancer transcriptional subtypes, tracks therapeutic targets in small-cell lung cancer, and identifies NECTIN4 expression as a biomarker of r...

G. Gulati, D. Vasseur, R. Nawfal et al. · 0 citations
Review Open access Sep 2026

30 Myeloid- Versus Effector-Driven Circulating Immune States Define Treatment-Specific Benefit in Metastatic Clear Cell Renal Cell Carcinoma

Abstract Background Metastatic clear cell renal cell carcinoma (ccRCC) first-line treatment relies on immune checkpoint inhibitor (ICI)-based regimens, including either dual ICI or ICI plus antiangiogenic tyrosine kinase inhibitor (TKI). Despite substantial clinical progress, predictive biomarkers guiding regimen selec...

M. Calabrese, N. Chaput, Marine Aglave et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.